Three large randomized controlled trials, each focused on a different daily routine, have produced converging evidence that ...

Millions of adults worry about memory loss as they age, yet the strongest medical evidence keeps pointing back to the same ...

Whole goat milk-based formula is associated with reduced risk for atopic dermatitis in infants, a randomized clinical trial ...

International Rescue Committee (IRC) and Partners Launch PlayMatters 3.0 to Expand Learning through Play across East Africa ...

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Atom Therapeutics, an innovative biotechnology company focused on the discovery and development of novel therapies for metabolic, inflammatory, and cardiovascular diseases, today announced the ...

Vivani CEO Adam Mendelsohn, Ph.D., stated, “HREC approval to initiate SLIM-1 in Australia marks an important moment for our Company, clearing the way for near-term, mid-2026, initiation. We are eager ...

BROADEN2 enrollment completed nearly six months ahead of anticipated timelines. KT-621 Phase 3 trials in AD planned to initiate by mid-2027. KT-621 BREADTH Phase 2b asthma trial o ...

Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...

ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America ...

Viking Therapeutics starts Phase 1 study on novel weight loss drug in healthy adults: San Diego Thursday, June 25, 2026, 18:00 Hrs [IST] Viking Therapeutics, Inc., a clinical-stag ...

ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America ...